Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations

por Lewis, Whitney E., Hong, Lingzhi, Mott, Frank E., Simon, George, Wu, Carol C., Rinsurongkawong, Waree, Lee, J. Jack, Lam, Vincent K., Heymach, John V., Zhang, Jianjun, Le, Xiuning
Publicado 2021

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

por Ruiz-Cordero, Roberto, Ma, Junsheng, Khanna, Abha, Lyons, Genevieve, Rinsurongkawong, Waree, Bassett, Roland, Guo, Ming, Routbort, Mark J., Zhang, Jianjun, Skoulidis, Ferdinandos, Heymach, John, Roarty, Emily B., Tang, Zhenya, Medeiros, L. Jeffrey, Patel, Keyur P., Luthra, Rajyalakshmi, Roy-Chowdhuri, Sinchita
Publicado 2020

Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab

por Liu, Yufei, Zhang, Zhe, Rinsurongkawong, Waree, Gay, Carl M., Le, Xiuning, Ning, Matthew S., Lewis, Jeff, Rinsurongkawong, Vadeerat, Lee, J. Jack, Roth, Jack, Swisher, Stephen, Gandhi, Saumil, Lee, Percy P., Gibbons, Don L., Vaporciyan, Ara A., Heymach, John V., Zhang, Jianjun, Lin, Steven H.
Publicado 2022

Clinical Outcomes in Non–Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling

por Tran, Hai T., Lam, Vincent K., Elamin, Yasir Y., Hong, Lingzhi, Colen, Rivka, Elshafeey, Nabil A., Hassan, Islam S. A., Altan, Mehmet, Blumenschein, George R., Rinsurongkawong, Waree, Rivera, Melvin J., Vasquez, Mayra E., Carter, Brett W., Byers, Lauren E., Tsao, Anne S., Gibbons, Don L., Fossella, Frank, Glisson, Bonnie S., Zhang, Jianjun, Heymach, John V.
Publicado 2021

ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC

por Vokes, Natalie I., Galan Cobo, Ana, Fernandez-Chas, Margarita, Molkentine, David, Treviño, Santiago, Druker, Vitaly, Qian, Yu, Patel, Sonia, Schmidt, Stephanie, Hong, Lingzhi, Lewis, Jeff, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Lee, J. Jack, Negrao, Marcelo V., Gibbons, Don L., Vaporciyan, Ara, Le, Xiuning, Wu, Jia, Zhang, Jianjun, Rigney, Una, Iyer, Sonia, Dean, Emma, Heymach, John V.
Publicado 2023

Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma

por Hong, Lingzhi, Lewis, Whitney E., Nilsson, Monique, Patel, Sonia, Varghese, Susan, Rivera, Melvin J., Du, Robyn R., Chen, Pingjun, Kemp, Haley N., Rinsurongkawong, Waree, Heeke, Simon, Spelman, Amy R., Elamin, Yasir Y., Negrao, Marcelo V., Sepesi, Boris, Gibbons, Don L., Lee, J. Jack, Wu, Jia, Vokes, Natalie I., Heymach, John V., Zhang, Jianjun, Le, Xiuning
Publicado 2022

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival

por De, Brian, Farooqi, Ahsan S., Mitchell, Kyle G., Ludmir, Ethan B., Lewis, Jeff, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Lee, J. Jack, Swisher, Stephen G., Gibbons, Don L., Zhang, Jianjun, Le, Xiuning, Elamin, Yasir Y., Gomez, Daniel R., Ning, Matthew S., Lin, Steven H., Liao, Zhongxing, Chang, Joe Y., Vaporciyan, Ara A., Heymach, John V., Antonoff, Mara B., Gandhi, Saumil J.
Publicado 2023

Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC

por Wang, Kaiwen, Du, Robyn, Roy-Chowdhuri, Sinchita, Li, Ziping T., Hong, Lingzhi, Vokes, Natalie, Elamin, Yasir Y., Hume, Celyne Bueno, Skoulidis, Ferdinandos, Gay, Carl M., Blumenschein, George, Fossella, Frank V., Tsao, Anne, Zhang, Jianjun, Karachaliou, Niki, O’Brate, Aurora, Gann, Claudia-Nanette, Lewis, Jeff, Rinsurongkawong, Waree, Lee, J. Jack, Gibbons, Don Lynn, Vaporciyan, Ara A., Heymach, John V., Altan, Mehmet, Le, Xiuning
Publicado 2023

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

por Altan, Mehmet, Soto, Felipe, Zhong, Linda L, Akhmedzhanov, Fechukwu O, Wilson, Nathaniel R, Zarifa, Abdulrazzak, Albittar, Aya A, Yang, Vincent, Lewis, Jeff, Rinsurongkawong, Waree, Jack Lee, J, Rinsurongkawong, Vadeerat, Zhang, Jianjun, Gibbons, Don L, Vaporciyan, Ara A, Jennings, Kristofer, Khawaja, Fareed, Faiz, Saadia A, Shannon, Vickie R, Shroff, Girish, Godoy, Myrna C B, Daver, Naval G, Gandhi, Saumil, Mendoza, Tito R, Naing, Aung, Daniel-MacDougall, Carrie, Heymach, John V, Sheshadri, Ajay
Publicado 2023

Structure-based classification predicts drug response in EGFR-mutant NSCLC

por Robichaux, Jacqulyne P., Le, Xiuning, Vijayan, R. S. K., Hicks, J. Kevin, Heeke, Simon, Elamin, Yasir Y., Lin, Heather Y., Udagawa, Hibiki, Skoulidis, Ferdinandos, Tran, Hai, Varghese, Susan, He, Junqin, Zhang, Fahao, Nilsson, Monique B., Hu, Lemei, Poteete, Alissa, Rinsurongkawong, Waree, Zhang, Xiaoshan, Ren, Chenghui, Liu, Xiaoke, Hong, Lingzhi, Zhang, Jianjun, Diao, Lixia, Madison, Russell, Schrock, Alexa B., Saam, Jennifer, Raymond, Victoria, Fang, Bingliang, Wang, Jing, Ha, Min Jin, Cross, Jason B., Gray, Jhanelle E., Heymach, John V.
Publicado 2021

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

por Negrao, Marcelo V, Skoulidis, Ferdinandos, Montesion, Meagan, Schulze, Katja, Bara, Ilze, Shen, Vincent, Xu, Hao, Hu, Sylvia, Sui, Dawen, Elamin, Yasir Y, Le, Xiuning, Goldberg, Michael E, Murugesan, Karthikeyan, Wu, Chang-Jiun, Zhang, Jianhua, Barreto, David S, Robichaux, Jacqulyne P, Reuben, Alexandre, Cascone, Tina, Gay, Carl M, Mitchell, Kyle G, Hong, Lingzhi, Rinsurongkawong, Waree, Roth, Jack A, Swisher, Stephen G, Lee, Jack, Tsao, Anne, Papadimitrakopoulou, Vassiliki, Gibbons, Don L, Glisson, Bonnie S, Singal, Gaurav, Miller, Vincent A, Alexander, Brian, Frampton, Garrett, Albacker, Lee A, Shames, David, Zhang, Jianjun, Heymach, John V
Publicado 2021

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer

por Hong, Lingzhi, Aminu, Muhammad, Li, Shenduo, Lu, Xuetao, Petranovic, Milena, Saad, Maliazurina B., Chen, Pingjun, Qin, Kang, Varghese, Susan, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Spelman, Amy, Elamin, Yasir Y., Negrao, Marcelo V., Skoulidis, Ferdinandos, Gay, Carl M., Cascone, Tina, Gandhi, Saumil J., Lin, Steven H., Lee, Percy P., Carter, Brett W., Wu, Carol C., Antonoff, Mara B., Sepesi, Boris, Lewis, Jeff, Gibbons, Don L., Vaporciyan, Ara A., Le, Xiuning, Jack Lee, J., Roy-Chowdhuri, Sinchita, Routbort, Mark J., Gainor, Justin F., Heymach, John V., Lou, Yanyan, Wu, Jia, Zhang, Jianjun, Vokes, Natalie I.
Publicado 2023

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers

por Alhalabi, Omar, Chen, Jianfeng, Zhang, Yuxue, Lu, Yang, Wang, Qi, Ramachandran, Sumankalai, Tidwell, Rebecca Slack, Han, Guangchun, Yan, Xinmiao, Meng, Jieru, Wang, Ruiping, Hoang, Anh G., Wang, Wei-Lien, Song, Jian, Lopez, Lidia, Andreev-Drakhlin, Alex, Siefker-Radtke, Arlene, Zhang, Xinqiao, Benedict, William F., Shah, Amishi Y., Wang, Jennifer, Msaouel, Pavlos, Zhang, Miao, Guo, Charles C., Czerniak, Bogdan, Behrens, Carmen, Soto, Luisa, Papadimitrakopoulou, Vassiliki, Lewis, Jeff, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Lee, Jack, Roth, Jack, Swisher, Stephen, Wistuba, Ignacio, Heymach, John, Wang, Jing, Campbell, Matthew T., Efstathiou, Eleni, Titus, Mark, Logothetis, Christopher J., Ho, Thai H., Zhang, Jianjun, Wang, Linghua, Gao, Jianjun
Publicado 2022

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

por Saad, Maliazurina B, Hong, Lingzhi, Aminu, Muhammad, Vokes, Natalie I, Chen, Pingjun, Salehjahromi, Morteza, Qin, Kang, Sujit, Sheeba J, Lu, Xuetao, Young, Elliana, Al-Tashi, Qasem, Qureshi, Rizwan, Wu, Carol C, Carter, Brett W, Lin, Steven H, Lee, Percy P, Gandhi, Saumil, Chang, Joe Y, Li, Ruijiang, Gensheimer, Michael F, Wakelee, Heather A, Neal, Joel W, Lee, Hyun-Sung, Cheng, Chao, Velcheti, Vamsidhar, Lou, Yanyan, Petranovic, Milena, Rinsurongkawong, Waree, Le, Xiuning, Rinsurongkawong, Vadeerat, Spelman, Amy, Elamin, Yasir Y, Negrao, Marcelo V, Skoulidis, Ferdinandos, Gay, Carl M, Cascone, Tina, Antonoff, Mara B, Sepesi, Boris, Lewis, Jeff, Wistuba, Ignacio I, Hazle, John D, Chung, Caroline, Jaffray, David, Gibbons, Don L, Vaporciyan, Ara, Lee, J Jack, Heymach, John V, Zhang, Jianjun, Wu, Jia
Publicado 2023